Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus.

MLA

Wang, Xuekun, et al. “Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus.” Molecules, vol. 27, no. 24, Dec. 2022, p. 9018. EBSCOhost, https://doi.org/10.3390/molecules27249018.

APA

Wang, X., Li, X., Wei, S., Wang, M., Xu, Y., Hu, W., Gao, Z., Liu, R., Wang, S., & Ji, G. (2022). Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus. Molecules, 27(24), 9018. https://doi.org/10.3390/molecules27249018

Chicago

Wang, Xuekun, Xu Li, Shiting Wei, Min Wang, Yao Xu, Weidi Hu, Zhenzhen Gao, Renmin Liu, Shiben Wang, and Guoxia Ji. 2022. “Discovery of Novel and Selective G-Protein Coupled Receptor 120 (GPR120) Agonists for the Treatment of Type 2 Diabetes Mellitus.” Molecules 27 (24): 9018. doi:10.3390/molecules27249018.